Jeonjinbio Co. Ltd (110020) — Financial Flexibility Index
Jeonjinbio Co. Ltd (110020) has a Financial Flexibility Index of 0.25x as of September 2025. Free cash flow of ₩323.26 Million (operating CF ₩313.21 Million minus capex ₩10.04 Million) represents 0% of total liabilities (₩1.27 Billion). Also explore net asset growth rate of Jeonjinbio Co. Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jeonjinbio Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Jeonjinbio Co. Ltd across 10 annual periods. Check Jeonjinbio Co. Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jeonjinbio Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Jeonjinbio Co. Ltd. For the full company profile including market capitalisation, see Jeonjinbio Co. Ltd (110020) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.85x | ₩3.40 Billion | ₩3.01 Billion | ₩1.19 Billion | ▲ +8728.1% |
| 2023 | 0.03x | ₩371.04 Million | ₩-300.60 Million | ₩11.48 Billion | ▲ +117.1% |
| 2022 | -0.19x | ₩-1.58 Billion | ₩-3.71 Billion | ₩8.36 Billion | ▼ -487.3% |
| 2021 | -0.03x | ₩-451.59 Million | ₩-2.38 Billion | ₩14.02 Billion | ▼ -106.8% |
| 2020 | 0.47x | ₩3.49 Billion | ₩-2.31 Billion | ₩7.41 Billion | ▲ +376.3% |
| 2019 | -0.17x | ₩-598.32 Million | ₩-1.30 Billion | ₩3.51 Billion | ▲ +74.4% |
| 2018 | -0.67x | ₩-2.13 Billion | ₩-2.16 Billion | ₩3.21 Billion | ▼ -519.7% |
| 2017 | -0.11x | ₩-410.76 Million | ₩-413.19 Million | ₩3.83 Billion | ▼ -1050.2% |
| 2016 | -0.01x | ₩-33.11 Million | ₩-181.90 Million | ₩3.55 Billion | ▲ +96.0% |
| 2015 | -0.23x | ₩-1.84 Billion | ₩-1.95 Billion | ₩7.95 Billion | — |